Since the 1990s, BSE has been one after another in Europe and the United States. In order to ensure the quality and safety of heparin sodium products, European and American pharmaceutical manufacturers stopped purchasing heparin sodium extracted from beef intestines and cattle lungs in Europe and America. Therefore, it objectively promoted the price stability and upward trend of heparin in small intestine of pigs in China. At the end of March 2010, global influenza A (H1N1) broke out in Mexico and the southwest of the United States. The international market set up a barrier for the export of heparin from Mexico. With the loss of the market share of Mexico's heparin, a large number of purchase orders of heparin were concentrated in China. For a time, the demand for heparin increased greatly, and the major heparin export enterprises also increased the purchase price in order to win more liver Source of plain goods.
The 21st century is an age of aging population. At present, all the developed countries in the world have entered the aging meeting, and many developing countries are or will enter the aging meeting. The incidence rate of cardiovascular and cerebrovascular diseases is also increasing rapidly. Therefore, the demand for thrombus drugs will increase in the global market. Heparin sodium is the basic raw material for the production of anticoagulant drugs, and the price of heparin sodium will naturally increase.
In October of last year, the retail price of heparin sodium injection for anticoagulant surgery increased from 4.5 yuan to 11.7 yuan. The price adjustment of drugs not only reflects the change of cost, but also reflects the high quality and good price. Especially after the "heparin sodium incident" in 2008, the new standard of USP, which came into effect on October 1, last year, not only improved the inspection methods of heparin sodium, but also comprehensively improved the acceptance standard of sodium heparin. Chinese enterprises also further strengthened production and quality management, so they finally entered the market Field is high potency, good quality of heparin sodium, the price will continue to rise.
In the past few years, developed countries in Europe and the United States were the main export markets of heparin sodium API in China. However, in recent years, some Eastern European countries such as Romania, Poland, Hungary, Bulgaria and other northern European countries, such as Denmark and Finland, have also become emerging markets for China's heparin sodium API exports, and the export speed has increased rapidly. The price of heparin sodium will rise again and again under the influence of market supply and demand factors.
